Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

A figure of the summary of costs and consequences to consider in COVID-19 vaccine HTA.

Who Gets a COVID-19 Vaccine and Who Pays? The Need for Economic Analysis

In 2020, epidemiological modelling went from relative obscurity to being central in helping governments, and the public, understand COVID-19 as it spread around the world. In 2021, with the emergence of effective COVID-19 vaccines, Health Technology Assessment (HTA) will be critical to making the best possible decisions in bringing the pandemic under control, particularly in low-and middle-income countries (LMICs). In this blog we look at the potential of HTA to inform how much vaccine countries should buy, who should pay, and how vaccines can be most effectively delivered.

Disease Forecasting during the COVID-19 Pandemic: Have We Learned from Previous Outbreaks?

Before COVID-19, the 2014-2015 West African Ebola epidemic (EVD epidemic), was one of the most heavily modelled outbreaks in history. Within the first two months of the COVID-19 pandemic, 31 mathematical models were developed. Despite the clear differences in the two outbreaks, the EVD epidemic can help us draw lessons to improve COVID-19 modelling and its reach in policymaking. We discuss some of those learnings in this piece